SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-24-000020
Filing Date
2024-05-03
Accepted
2024-05-03 07:10:35
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q howl-20240331.htm   iXBRL 10-Q 1230423
2 EX-31.1 a03312024ex311.htm EX-31.1 10333
3 EX-31.2 a03312024ex312.htm EX-31.2 10357
4 EX-32.1 a03312024ex321.htm EX-32.1 7034
  Complete submission text file 0001785530-24-000020.txt   4980406

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20240331.xsd EX-101.SCH 35485
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT howl-20240331_cal.xml EX-101.CAL 46728
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT howl-20240331_def.xml EX-101.DEF 181462
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20240331_lab.xml EX-101.LAB 424630
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20240331_pre.xml EX-101.PRE 315707
66 EXTRACTED XBRL INSTANCE DOCUMENT howl-20240331_htm.xml XML 451992
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 24910775
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)